145 related articles for article (PubMed ID: 38029034)
1. Histomorphological Evaluation of Desmoplastic Tumor Stroma in Malignant Ovarian Surface Epithelial Tumors.
Ahuja S; Zaheer S; Ranga S
J Midlife Health; 2023; 14(2):107-111. PubMed ID: 38029034
[TBL] [Abstract][Full Text] [Related]
2. Role of tumor budding and fibrotic cancer stroma in head and neck squamous cell carcinoma.
Mitha M; Aden D; Zaheer S; Alvi Y; Chintamani
Pathol Res Pract; 2024 Jan; 253():155052. PubMed ID: 38176309
[TBL] [Abstract][Full Text] [Related]
3. Joint Tumor Bud-MMP/TIMP Count at the Invasive Front Improves the Prognostic Evaluation of Invasive Breast Carcinoma.
González LO; Eiro N; Fraile M; Sánchez R; Andicoechea A; Fernández-Francos S; Schneider J; Vizoso FJ
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33669393
[TBL] [Abstract][Full Text] [Related]
4. Histological categorisation of fibrotic cancer stroma in advanced rectal cancer.
Ueno H; Jones AM; Wilkinson KH; Jass JR; Talbot IC
Gut; 2004 Apr; 53(4):581-6. PubMed ID: 15016755
[TBL] [Abstract][Full Text] [Related]
5. HtrA3 stromal expression is correlated with tumor budding in stage II colorectal cancer.
Forse CL; Rahimi M; Diamandis EP; Assarzadegan N; Dawson H; Grin A; Kennedy E; O'Connor B; Messenger DE; Riddell RH; Kirsch R; Karagiannis GS
Exp Mol Pathol; 2017 Aug; 103(1):94-100. PubMed ID: 28716573
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
7. Cancer-Associated Fibroblasts and Desmoplastic Reactions Related to Cancer Invasiveness in Patients With Colorectal Cancer.
Shin N; Son GM; Shin DH; Kwon MS; Park BS; Kim HS; Ryu D; Kang CD
Ann Coloproctol; 2019 Feb; 35(1):36-46. PubMed ID: 30879282
[TBL] [Abstract][Full Text] [Related]
8. Desmoplastic Pattern at the Tumor Front Defines Poor-prognosis Subtypes of Colorectal Cancer.
Ueno H; Kanemitsu Y; Sekine S; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Mochizuki S; Kajiwara Y; Shinto E; Yamamoto J
Am J Surg Pathol; 2017 Nov; 41(11):1506-1512. PubMed ID: 28877064
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
Sandberg TP; Stuart MPME; Oosting J; Tollenaar RAEM; Sier CFM; Mesker WE
BMC Cancer; 2019 Mar; 19(1):284. PubMed ID: 30922247
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Tumour Budding and Desmoplastic Reaction in Intestinal-Type Gastric Adenocarcinoma.
Pun C; Luu S; Swallow C; Kirsch R; Conner JR
Int J Surg Pathol; 2023 Sep; 31(6):957-966. PubMed ID: 35726174
[No Abstract] [Full Text] [Related]
11. Disentangling the prognostic heterogeneity of stage III colorectal cancer through histologic stromal categorization.
Ueno H; Sekine S; Oshiro T; Kanemitsu Y; Hamaguchi T; Shida D; Takashima A; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Mochizuki S; Kajiwara Y; Shinto E; Yamamoto J; Shimada Y
Surgery; 2018 Apr; 163(4):777-783. PubMed ID: 29162344
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of tumour budding, tumour-stroma ratio and desmoplastic stromal reaction in gall bladder carcinoma.
Goyal S; Banga P; Meena N; Chauhan G; Sakhuja P; Agarwal AK
J Clin Pathol; 2023 May; 76(5):308-314. PubMed ID: 34853164
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 Stromal Expression is Correlated with Epithelial-Mesenchymal Transition at Tumor Budding in Colorectal Cancer.
Uehara T; Sato K; Iwaya M; Asaka S; Nakajima T; Nagaya T; Kitazawa M; Ota H
Int J Surg Pathol; 2024 Apr; 32(2):304-309. PubMed ID: 37306249
[No Abstract] [Full Text] [Related]
14. Tumor budding at the invasive front of colorectal cancer may not be associated with the epithelial-mesenchymal transition.
Yamada N; Sugai T; Eizuka M; Tsuchida K; Sugimoto R; Mue Y; Suzuki M; Osakabe M; Uesugi N; Ishida K; Otsuka K; Matsumoto T
Hum Pathol; 2017 Feb; 60():151-159. PubMed ID: 27836787
[TBL] [Abstract][Full Text] [Related]
15. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining.
Blank A; Schenker C; Dawson H; Beldi G; Zlobec I; Lugli A
Front Med (Lausanne); 2019; 6():247. PubMed ID: 31737639
[TBL] [Abstract][Full Text] [Related]
17. Stromal categorization in early oral tongue cancer.
Almangush A; Bello IO; Heikkinen I; Hagström J; Haglund C; Kowalski LP; Nieminen P; Coletta RD; Mäkitie AA; Salo T; Leivo I
Virchows Arch; 2021 May; 478(5):925-932. PubMed ID: 32955604
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of cytokeratin and vimentin in colorectal cancer highlights a subset of tumor buds and an atypical cancer-associated stroma.
Meyer SN; Galván JA; Zahnd S; Sokol L; Dawson H; Lugli A; Zlobec I
Hum Pathol; 2019 May; 87():18-27. PubMed ID: 30794893
[TBL] [Abstract][Full Text] [Related]
19. Tumor budding and fibrotic focus-proposed grading system for tumor budding in invasive carcinoma no special type of the breast.
Hiratsuka M; Hasebe T; Ichinose Y; Sakakibara A; Fujimoto A; Wakui N; Shibasaki S; Hirasaki M; Yasuda M; Nukui A; Shimada H; Yokogawa H; Matsuura K; Hojo T; Osaki A; Saeki T
Virchows Arch; 2022 Aug; 481(2):161-190. PubMed ID: 35695928
[TBL] [Abstract][Full Text] [Related]
20. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
